Abstract
MicroRNAs (miRNAs) are known for their role in the post-transcriptional regulation of messenger RNA (mRNA). However, recent evidence has shown that miRNAs are capable of regulating non-coding RNAs, including miRNAs, in what is known as miRNA:miRNA interactions. There are three main models for the interplay between miRNAs. These involve direct interaction between two miRNAs, either in their mature or primary form, the subsequent changes in miRNA expression due to miRNA-directed transcriptional changes, and the cell-wide impact on miRNA and mRNA levels as a result of miRNA manipulation. Networks of mRNA and miRNA regulatory connections are invaluable to the discovery of miRNA:miRNA pathways, but this cannot be applied without consideration of the specific cell type or condition.
In this chapter, we discuss what is understood about miRNA:miRNA interactions, their mechanisms and consequences in disease biology, and suggest further avenues of investigation based on current gaps in the literature and in our understanding of miRNA biology. We also address the pitfalls in contemporary methods relating to the identification of miRNA:miRNA interactions. Future work in this area may ultimately change the definitional role of miRNAs, and have far-reaching impacts on therapeutic and diagnostic developments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agarwal V, Bell GW, Nam J-W, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. eLife 4:e05005. https://doi.org/10.7554/eLife.05005
Aguda BD, Kim Y, Piper-Hunter MG, Friedman A, Marsh CB (2008) MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci 105(50):19678–19683
Bertero T, Lu Y, Annis S, Hale A, Bhat B, Saggar R, Saggar R, Wallace WD, Ross DJ, Vargas SO, Graham BB, Kumar R, Black SM, Fratz S, Fineman JR, West JD, Haley KJ, Waxman AB, Chau BN, Cottrill KA, Chan SY (2014) Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension. J Clin Invest 124(8):3514–3528. https://doi.org/10.1172/JCI74773
Bofill-De Ros X, Yang A, Gu S (2020) IsomiRs: expanding the miRNA repression toolbox beyond the seed. Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1863(4):194373
Borzi C, Calzolari L, Centonze G, Milione M, Sozzi G, Fortunato O (2017) Mir-660-p53-mir-486 network: a new key regulatory pathway in lung tumorigenesis. Int J Mol Sci 18(1). https://doi.org/10.3390/ijms18010222
Chang T-C, Pertea M, Lee S, Salzberg SL, Mendell JT (2015) Genome-wide annotation of microRNA primary transcript structures reveals novel regulatory mechanisms. Genome Res 25(9):1401–1409
Chen PS, Su JL, Cha ST, Tarn WY, Wang MY, Hsu HC, Lin MT, Chu CY, Hua KT, Chen CN, Kuo TC, Chang KJ, Hsiao M, Chang YW, Chen JS, Yang PC, Kuo ML (2011) miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. J Clin Invest 121(9):3442–3455. https://doi.org/10.1172/JCI45390
Chou C-H, Shrestha S, Yang C-D, Chang N-W, Lin Y-L, Liao K-W, Huang W-C, Sun T-H, Tu S-J, Lee W-H (2018) miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res 46(D1):D296–D302
Cilek EE, Ozturk H, Gur Dedeoglu B (2017) Construction of miRNA-miRNA networks revealing the complexity of miRNA-mediated mechanisms in trastuzumab treated breast cancer cell lines. PLoS One 12(10):e0185558. https://doi.org/10.1371/journal.pone.0185558
Conrad T, Ntini E, Lang B, Cozzuto L, Andersen JB, Marquardt JU, Ponomarenko J, Tartaglia GG, Orom UAV (2020) Determination of primary microRNA processing in clinical samples by targeted pri-miR-sequencing. bioRxiv
Fang W, Bartel DP (2020) MicroRNA clustering assists processing of suboptimal MicroRNA hairpins through the action of the ERH protein. Mol Cell 78(2):289–302.e286. https://doi.org/10.1016/j.molcel.2020.01.026
Flamand MN, Gan HH, Mayya VK, Gunsalus KC, Duchaine TF (2017) A non-canonical site reveals the cooperative mechanisms of microRNA-mediated silencing. Nucleic Acids Res. https://doi.org/10.1093/nar/gkx340
Forrest AR, Kanamori-Katayama M, Tomaru Y, Lassmann T, Ninomiya N, Takahashi Y, de Hoon MJ, Kubosaki A, Kaiho A, Suzuki M, Yasuda J, Kawai J, Hayashizaki Y, Hume DA, Suzuki H (2010) Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 24(2):460–466. https://doi.org/10.1038/leu.2009.246
Grillone K, Riillo C, Scionti F, Rocca R, Tradigo G, Guzzi PH, Alcaro S, Di Martino MT, Tagliaferri P, Tassone P (2020) Non-coding RNAs in cancer: platforms and strategies for investigating the genomic “dark matter”. J Exp Clin Cancer Res 39(1):1–19
Gruszka R, Zakrzewski K, Liberski PP, Zakrzewska M (2021) mRNA and miRNA expression analyses of the MYC/E2F/miR-17-92 network in the Most common pediatric brain tumors. Int J Mol Sci 22(2):543
Guo L, Sun B, Wu Q, Yang S, Chen F (2012) miRNA-miRNA interaction implicates for potential mutual regulatory pattern. Gene 511(2):187–194. https://doi.org/10.1016/j.gene.2012.09.066
Hata A, Kashima R (2016) Dysregulation of microRNA biogenesis machinery in cancer. Crit Rev Biochem Mol Biol 51(3):121–134. https://doi.org/10.3109/10409238.2015.1117054
Huang H-Y, Lin Y-C-D, Li J, Huang K-Y, Shrestha S, Hong H-C, Tang Y, Chen Y-G, Jin C-N, Yu Y, Xu J-T, Li Y-M, Cai X-X, Zhou Z-Y, Chen X-H, Pei Y-Y, Hu L, Su J-J, Cui S-D, Wang F, Xie Y-Y, Ding S-Y, Luo M-F, Chou C-H, Chang N-W, Chen K-W, Cheng Y-H, Wan X-H, Hsu W-L, Lee T-Y, Wei F-X, Huang H-D (2019) miRTarBase 2020: updates to the experimentally validated microRNA–target interaction database. Nucleic Acids Res 48(D1):D148–D154. https://doi.org/10.1093/nar/gkz896
Jia L-F, Zheng Y-F, Lyu M-Y, Huang Y-P, Gan Y-H (2016) miR-29b upregulates miR-195 by targeting DNMT3B in tongue squamous cell carcinoma. Science Bulletin 61(3):212–219. https://doi.org/10.1007/s11434-016-1001-6
Khan AA, Betel D, Miller ML, Sander C, Leslie CS, Marks DS (2009) Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat Biotechnol 27(6):549–555
Kim B, Jeong K, Kim VN (2017) Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and noncanonical substrates. Mol Cell 66(2):258–269. e255
Kim YK, Kim B, Kim VN (2016) Re-evaluation of the roles of DROSHA, export in 5, and DICER in microRNA biogenesis. Proc Natl Acad Sci U S A 113(13):E1881–E1889. https://doi.org/10.1073/pnas.1602532113
Kishore S, Jaskiewicz L, Burger L, Hausser J, Khorshid M, Zavolan M (2011) A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. Nat Methods 8(7):559–564
Kretov DA, Walawalkar IA, Mora-Martin A, Shafik AM, Moxon S, Cifuentes D (2020) Ago2-dependent processing allows miR-451 to evade the global MicroRNA turnover elicited during erythropoiesis. Mol Cell 78(2):317–328.e316. https://doi.org/10.1016/j.molcel.2020.02.020
Króliczewski J, Sobolewska A, Lejnowski D, Collawn JF, Bartoszewski R (2018) microRNA single polynucleotide polymorphism influences on microRNA biogenesis and mRNA target specificity. Gene 640:66–72
Lai EC, Wiel C, Rubin GM (2004) Complementary miRNA pairs suggest a regulatory role for miRNA:miRNA duplexes. RNA 10(2):171–175
Lapa RML, Barros-Filho MC, Marchi FA, Domingues MAC, de Carvalho GB, Drigo SA, Kowalski LP, Rogatto SR (2019) Integrated miRNA and mRNA expression analysis uncovers drug targets in laryngeal squamous cell carcinoma patients. Oral Oncol 93:76–84
Leonov G, Shah K, Yee D, Timmis J, Sharp TV, Lagos D (2015) Suppression of AGO2 by miR-132 as a determinant of miRNA-mediated silencing in human primary endothelial cells. Int J Biochem Cell Biol 69:75–84. https://doi.org/10.1016/j.biocel.2015.10.006
Lewis BP, Shih I-h, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115(7):787–798
Liu Y, Ye F (2019) Construction and integrated analysis of crosstalking ceRNAs networks in laryngeal squamous cell carcinoma. PeerJ 7:e7380
Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH, Li Y (2008) MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27(31):4373–4379. https://doi.org/10.1038/onc.2008.72
Matkovich SJ, Hu Y, Dorn GW 2nd (2013) Regulation of cardiac microRNAs by cardiac microRNAs. Circ Res 113(1):62–71. https://doi.org/10.1161/CIRCRESAHA.113.300975
Matsuyama H, Suzuki HI (2019) Systems and synthetic microRNA biology: from biogenesis to disease pathogenesis. Int J Mol Sci 21(1):132. https://doi.org/10.3390/ijms21010132
Nam J-W, Rissland OS, Koppstein D, Abreu-Goodger C, Jan CH, Agarwal V, Yildirim MA, Rodriguez A, Bartel DP (2014) Global analyses of the effect of different cellular contexts on microRNA targeting. Mol Cell 53(6):1031–1043
Ooi JYY, Bernardo BC, Singla S, Patterson NL, Lin RCY, McMullen JR (2017) Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: implications for treating cardiac pathology and other diseases. RNA Biol 14(5):500–513. https://doi.org/10.1080/15476286.2016.1181251
Park JH, Shin SY, Shin C (2017) Non-canonical targets destabilize microRNAs in human Argonautes. Nucleic Acids Res 45(4):1569–1583. https://doi.org/10.1093/nar/gkx029
Pickering MT, Stadler BM, Kowalik TF (2009) miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression. Oncogene 28(1):140–145
Rock LD, Minatel BC, Marshall EA, Guisier F, Sage AP, Barros-Filho MC, Stewart GL, Garnis C, Lam WL (2019) Expanding the transcriptome of head and neck squamous cell carcinoma through novel MicroRNA discovery. Front Oncol 9:1305
Salmanidis M, Pillman K, Goodall G, Bracken C (2014) Direct transcriptional regulation by nuclear microRNAs. Int J Biochem Cell Biol 54:304–311
Shahab SW, Matyunina LV, Mittal VK, Wang L, Hill CG, Walker LD, McDonald JF (2012) MicroRNAs indirectly regulate other microRNAs in ovarian cancer cells. British J Med Med Res 2(2):172
Shang R, Baek SC, Kim K, Kim B, Kim VN, Lai EC (2020) Genomic clustering facilitates nuclear processing of suboptimal Pri-miRNA loci. Mol Cell 78(2):303–316.e304. https://doi.org/10.1016/j.molcel.2020.02.009
Song C, Xu Z, Jin Y, Zhu M, Wang K, Wang N (2015) The network of microRNAs, transcription factors, target genes and host genes in human renal cell carcinoma. Oncol Lett 9(1):498–506. https://doi.org/10.3892/ol.2014.2683
Stoen MJ, Andersen S, Rakaee M, Pedersen MI, Ingebriktsen LM, Donnem T, Lombardi AP, Kilvaer TK, Busund L-TR, Richardsen E (2021) Overexpression of miR-20a-5p in tumor epithelium is an independent negative prognostic indicator in prostate cancer–a multi-institutional study. Cancers 13(16):4096
Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F, Ferbeyre G, Chartrand P (2007) An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 282(4):2135–2143. https://doi.org/10.1074/jbc.M608939200
Tang R, Li L, Zhu D, Hou D, Cao T, Gu H, Zhang J, Chen J, Zhang CY, Zen K (2012) Mouse miRNA-709 directly regulates miRNA-15a/16-1 biogenesis at the posttranscriptional level in the nucleus: evidence for a microRNA hierarchy system. Cell Res 22(3):504–515. https://doi.org/10.1038/cr.2011.137
van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, Kelm RJ Jr, Olson EN (2009) A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 17(5):662–673. https://doi.org/10.1016/j.devcel.2009.10.013
Vedanayagam J, Chatila WK, Aksoy BA, Majumdar S, Skanderup AJ, Demir E, Schultz N, Sander C, Lai EC (2019) Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis. Nat Commun 10(1):3682. https://doi.org/10.1038/s41467-019-11610-1
Wang D, Sun X, Wei Y, Liang H, Yuan M, Jin F, Chen X, Liu Y, Zhang CY, Li L, Zen K (2018a) Nuclear miR-122 directly regulates the biogenesis of cell survival oncomiR miR-21 at the posttranscriptional level. Nucleic Acids Res 46(4):2012–2029. https://doi.org/10.1093/nar/gkx1254
Wang K, Sun T, Li N, Wang Y, Wang JX, Zhou LY, Long B, Liu CY, Liu F, Li PF (2014) MDRL lncRNA regulates the processing of miR-484 primary transcript by targeting miR-361. PLoS Genet 10(7):e1004467. https://doi.org/10.1371/journal.pgen.1004467
Wang Y, Bao W, Liu Y, Wang S, Xu S, Li X, Li Y, Wu S (2018b) miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1. Cell Death Dis 9(5):447. https://doi.org/10.1038/s41419-018-0390-7
Yu Y, Nangia-Makker P, Farhana L, S GR, Levi E, Majumdar AP (2015) miR-21 and miR-145 cooperation in regulation of colon cancer stem cells. Mol Cancer 14:98. https://doi.org/10.1186/s12943-015-0372-7
Zisoulis DG, Kai ZS, Chang RK, Pasquinelli AE (2012) Autoregulation of microRNA biogenesis by let-7 and Argonaute. Nature 486(7404):541–544. https://doi.org/10.1038/nature11134
Acknowledgments
MH is supported by an Australian Research Training Program Scholarship and a Translational Cancer Research Network PhD Scholarship Top-Up Award, supported by the Cancer Institute NSW.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hill, M., Tran, N. (2022). miRNA:miRNA Interactions: A Novel Mode of miRNA Regulation and Its Effect On Disease. In: Schmitz, U., Wolkenhauer, O., Vera-González, J. (eds) Systems Biology of MicroRNAs in Cancer. Advances in Experimental Medicine and Biology, vol 1385. Springer, Cham. https://doi.org/10.1007/978-3-031-08356-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-031-08356-3_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-08355-6
Online ISBN: 978-3-031-08356-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)